Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 122 (3), 434-444

Stathmin Levels Alter PTPN14 Expression and Impact Neuroblastoma Cell Migration

Affiliations

Stathmin Levels Alter PTPN14 Expression and Impact Neuroblastoma Cell Migration

Sela T Po'uha et al. Br J Cancer.

Abstract

Background: Stathmin mediates cell migration and invasion in vitro, and metastasis in vivo. To investigate stathmin's role on the metastatic process, we performed integrated mRNA-miRNA expression analysis to identify pathways regulated by stathmin.

Methods: MiRNA and gene arrays followed by miRNA-target-gene integration were performed on stathmin-depleted neuroblastoma cells (CtrlshRNA vs. Stmn Seq2shRNA). The expression of the predicted target PTPN14 was evaluated by RT-qPCR, western blot and immunohistochemistry. Gene-silencing technology was used to assess the role of PTPN14 on proliferation, migration, invasion and signalling pathway.

Results: Stathmin levels modulated the expression of genes and miRNA in neuroblastoma cells, leading to a deregulation of migration and invasion pathways. Consistent with gene array data, PTPN14 mRNA and protein expression were downregulated in stathmin- depleted neuroblastoma cells and xenografts. In two independent neuroblastoma cells, suppression of PTPN14 expression led to an increase in cell migration and invasion. PTPN14 and stathmin expression did not act in a feedback regulatory loop in PTPN14- depleted cells, suggesting a complex interplay of signalling pathways. The effect of PTPN14 on YAP pathway activation was cell-type dependent.

Conclusions: Our findings demonstrate that stathmin levels can regulate PTPN14 expression, which can modulate neuroblastoma cell migration and invasion.

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Irwin MS, Park JR. Neuroblastoma: paradigm for precision medicine. Pediatr. Clin. North Am. 2015;62:225–256. doi: 10.1016/j.pcl.2014.09.015. - DOI - PubMed
    1. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369:2106–2120. doi: 10.1016/S0140-6736(07)60983-0. - DOI - PubMed
    1. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006;12:895–904. doi: 10.1038/nm1469. - DOI - PubMed
    1. Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br. J. Pharmacol. 2014;171:5507–5523. doi: 10.1111/bph.12704. - DOI - PMC - PubMed
    1. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC, et al. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18) Oncogene. 1990;5:1615–1618. - PubMed

LinkOut - more resources

Feedback